By using immunogenetic datasets from MSKCC and UCLA groups 39, 41, we found that mutations in core CDH genes highly correlated with total mutational and neo-antigen loads in patients with metastatic melanoma (Figure 8B-C). The gene discussed is CHDH; the disease is metastatic melanoma.